[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China].

Zhang, W; Chen, Z; Li, X M; Gao, J; Zhao, Y

Zhang, W; Chen, Z; Li, X M; Gao, J; Zhao, Y.

Affiliation

Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology,State Key Laboratory of Comp
Chen Z; Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei 230001, China.
Li XM; Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei 230001, China.
Gao J; Department of Rheumatology and Immunology, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology,State Key Laboratory of Comp

Zhonghua Nei Ke Za Zhi ; 62(9): 1059-1067, 2023 Sep 01.

Article in Zh | MEDLINE | ID: mdl-37650179

Subject(s)

Arthritis, Rheumatoid; Sjogren's Syndrome; Humans; Autoantibodies; China; Sjogren's Syndrome/diagnosis; Sjogren's Syndrome/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Sjogren's Syndrome Type of study: Diagnostic_studies / Guideline Limits: Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Nei Ke Za Zhi Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google